Nothing said here yet.
to join the conversation.
| Hollar Jason M.Chief Executive Officer | Sell | 16,187 | $3.8M | Wed, Aug 19 |
| Hollar Jason M.Chief Executive Officer | Sell | 6,731 | $1.6M | Wed, Aug 19 |
| Hollar Jason M.Chief Executive Officer | Sell | 6,244 | $1.5M | Wed, Aug 19 |
| Hollar Jason M.Chief Executive Officer | Sell | 6,206 | $1.4M | Wed, Aug 19 |
| Hollar Jason M.Chief Executive Officer | Sell | 5,704 | $1.3M | Wed, Aug 19 |
| Hollar Jason M.Chief Executive Officer | Sell | 3,457 | $809.9K | Wed, Aug 19 |
| Scherer Mary C.Chief Accounting Officer | Sell | 2,202 | $522.7K | Wed, Aug 19 |
| Scherer Mary C.Chief Accounting Officer | Sell | 100 | $23.7K | Wed, Aug 19 |
| Hollar Jason M.Chief Executive Officer | Sell | 29,915 | $7.0M | Tue, Aug 18 |
| Hollar Jason M.Chief Executive Officer | Sell | 21,407 | $5.0M | Tue, Aug 18 |
| Hollar Jason M.Chief Executive Officer | Sell | 16,208 | $3.8M | Tue, Aug 18 |
| Alt Aaron EChief Financial Officer | Sell | 13,685 | $3.2M | Tue, Aug 18 |
| Alan Armstrong | Buy | $8.0K | Fri, Mar 27 | Tue, Jul 21 |
For questions about this article or underlying research, email [email protected].
Cardinal Health is preparing to report earnings in early November 2026, with forecasts pointing to higher earnings per share and revenue compared with the prior year.
Cardinal Health earnings event puts the spotlight on sentiment Cardinal Health (CAH) heads into its planned November 5, 2026 earnings release with fresh attention after Mizuho raised expectations and the stock recently pushed through one technical entry and…
Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- "Disposable Specimen Container Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Cardinal Health (CAH) concluded the recent trading session at $257.55, signifying a +1.94% move from its prior day's close.
AbbVie, meanwhile, closed just shy of a record high, with shares ticking up 0.6% to $283.40.
MOUNTAIN VIEW, Calif., Oct.
Cardinal Health is set to report its Q1 results next month, with analysts expecting double-digit year-over-year EPS growth.
Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks.
Cardinal Health (CAH) closed the most recent trading day at $233.12, moving +2.11% from the previous trading session.